IGHE and Alzheimer disease: Most patients with AD have eosinophilia and increased serum IgE concentrations.[5,6] Many studies using various experimental models have shown that BZYQT has immunoregulatory effects.[13–19] These properties are also beneficial for alleviating AD symptoms in clinical practice.